What is the best pharmacologic treatment for sickle cell disease pain crises? (отвара нови прозор)

Baker M, Hafner JW.

Извор‎: Ann Emerg Med 2012;59(6):515-6.

Индекс‎: PubMed 22221839

DOI‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 (отвара нови прозор)

Multi-modal intervention and prospective implementation of standardized sickle cell pain admission orders reduces 30-day readmission rate. (отвара нови прозор)

Frei-Jones MJ, Field JJ, DeBaun MR.

Извор‎: Pediatr Blood Cancer 2009;53(3):401-5.

Индекс‎: PubMed 19422031

DOI‎: 10.1002/pbc.22048

https://www.ncbi.nlm.nih.gov/pubmed/19422031 (отвара нови прозор)

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (отвара нови прозор)

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

Извор‎: Thromb Haemost 2007;98(2):392-6.

Индекс‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 (отвара нови прозор)

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (отвара нови прозор)

Okomo U, Meremikwu MM.

Извор‎: Cochrane Database Syst Rev 2012;(6):CD005406.

Индекс‎: PubMed 22696351

DOI‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 (отвара нови прозор)

Guidelines for the management of the acute painful crisis in sickle cell disease. (отвара нови прозор)

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

Извор‎: Br J Haematol 2003;120(5):744-52.

Индекс‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 (отвара нови прозор)

The use of incentive spirometry in pediatric patients with sickle cell disease to reduce the incidence of acute chest syndrome. (отвара нови прозор)

Ahmad FA, Macias CG, Allen JY.

Извор‎: J Pediatr Hematol Oncol 2011;33(6):415-20.

Индекс‎: PubMed 21792036

DOI‎: 10.1097/MPH.0b013e31821ed4ce

https://www.ncbi.nlm.nih.gov/pubmed/21792036 (отвара нови прозор)

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (отвара нови прозор)

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

Извор‎: Hemoglobin 2004;28(2):85-102.

Индекс‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 (отвара нови прозор)

Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. (отвара нови прозор)

Bernini JC, Rogers ZR, Sandler ES, Reisch JS, Quinn CT, Buchanan GR.

Извор‎: Blood 1998;92(9):3082-9.

Индекс‎: PubMed 9787142

https://www.ncbi.nlm.nih.gov/pubmed/9787142 (отвара нови прозор)

A short course of prednisone in the management of acute chest syndrome of sickle cell disease. (отвара нови прозор)

Kumar R, Qureshi S, Mohanty P, Rao SP, Miller ST.

Извор‎: J Pediatr Hematol Oncol 2010;32(3):e91-4.

Индекс‎: PubMed 20216237

DOI‎: 10.1097/MPH.0b013e3181c29c52

https://www.ncbi.nlm.nih.gov/pubmed/20216237 (отвара нови прозор)

A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. (отвара нови прозор)

Morris CR, Kuypers FA, Lavrisha L, Ansari M, Sweeters N, Stewart M, Gildengorin G, Neumayr L, Vichinsky EP.

Извор‎: Haematologica 2013;98(9):1375-82.

Индекс‎: PubMed 23645695

DOI‎: 10.3324/haematol.2013.086637

https://www.ncbi.nlm.nih.gov/pubmed/23645695 (отвара нови прозор)

Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. (отвара нови прозор)

Weiner DL, Hibberd PL, Betit P, Cooper AB, Botelho CA, Brugnara C.

Извор‎: JAMA 2003;289(9):1136-42.

Индекс‎: PubMed 12622584

https://www.ncbi.nlm.nih.gov/pubmed/12622584 (отвара нови прозор)

Predictors of bacteremia in febrile children with sickle cell disease. (отвара нови прозор)

West DC, Andrada E, Azari R, Rangaswami AA, Kuppermann N.

Извор‎: J Pediatr Hematol Oncol 2002;24(4):279-83.

Индекс‎: PubMed 11972096

https://www.ncbi.nlm.nih.gov/pubmed/11972096 (отвара нови прозор)